| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 11/08/2001 | US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 11/08/2001 | US20010039016 Measurement, calibration gene expression |
| 11/08/2001 | US20010037810 Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment |
| 11/08/2001 | DE10020674A1 Treatment of headaches, especially migraine, by administration of aqueous copper sulfate solution, preferably as nose drops or nasal spray |
| 11/07/2001 | EP1151751A1 Cataplasms containing vitamin c or its derivative |
| 11/07/2001 | EP1150939A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer |
| 11/07/2001 | EP1150728A1 Methods and compositions for use in perfusion applications |
| 11/07/2001 | EP1150684A1 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts |
| 11/07/2001 | EP1150569A1 Method for reducing hip joint laxity |
| 11/07/2001 | EP1089620A4 Hydrophilic polymer blends used to prevent cow skin infections |
| 11/07/2001 | EP1042312B1 PHOTOCHROMIC INDENO-FUSED NAPHTHO[2,1-b]PYRANS |
| 11/07/2001 | EP0980205A4 Method of treating malignancies |
| 11/07/2001 | EP0799048B1 Body fluid replacement solution |
| 11/07/2001 | CN1320428A Instant effervescent particles for Ca-supplementing health-care products and its preparing process |
| 11/07/2001 | CN1074269C Food fortification |
| 11/06/2001 | US6313170 For therapy of nutritional iron-deficiency anemia, blood loss anemia and hemolytic anemia in humans |
| 11/06/2001 | US6312735 Applying slaked lime to the surface followed by rupture of surface of warts or moles with stub of stem of betel leaf |
| 11/06/2001 | US6312734 Forming an oxidized glutatione complex with platinum or palladium |
| 11/06/2001 | US6312705 Complexes of iodine with nylon |
| 11/06/2001 | US6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation |
| 11/06/2001 | US6312663 Prediction of diabetes impaired wound healing by urinary nitrate assay |
| 11/01/2001 | WO2001081246A2 Treatment of fluids |
| 11/01/2001 | WO2001080920A2 Antimicrobial bioabsorbable materials |
| 11/01/2001 | WO2001080890A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| 11/01/2001 | WO2001080842A2 Compositions comprising a methylnogarol in combination with an antiproliferative agent |
| 11/01/2001 | WO2001080832A2 Administration of a thiol-based chemoprotectant compound |
| 11/01/2001 | WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients |
| 11/01/2001 | WO2001028570A3 Zinc lactate lozenges and uses thereof |
| 11/01/2001 | US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 11/01/2001 | US20010036929 Dna repair |
| 11/01/2001 | US20010036635 Cancer screening |
| 11/01/2001 | US20010036482 Antimicrobial compositions for mastitis control |
| 11/01/2001 | US20010036468 Soft chewable multivitamin tablet comprising separated active ingredients |
| 11/01/2001 | US20010036445 Method of making chewing gum containing colloidal bismuth subcitrate |
| 11/01/2001 | US20010036442 Stool marker |
| 11/01/2001 | CA2307393A1 Ginsenoside chemotherapy |
| 10/31/2001 | EP1043988A4 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities |
| 10/31/2001 | EP0966291B1 Medicinal preparation containing a lipophilic inert gas |
| 10/31/2001 | EP0868125B1 Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent |
| 10/31/2001 | EP0444181B1 C-erbb-2 external domain: gp75 |
| 10/31/2001 | CN1319426A Oral traditional Chinese medicine for treating calculus stone in urinary system |
| 10/31/2001 | CN1319399A Medicine for curing burn and scald |
| 10/31/2001 | CN1073852C Medicine powder for treating hepatitis A and hepatitis B |
| 10/31/2001 | CN1073851C High efficiency ointment for curing beri-beri (tinea pedis) |
| 10/30/2001 | US6309677 Mixture of algal extract containing alpha and beta carotene, plam fruit extract containing alpha and beta carotene and a marigold flower extract containing lutein |
| 10/30/2001 | US6309673 Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy |
| 10/30/2001 | US6309672 Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition |
| 10/30/2001 | CA2175830C Application of trace elements to animals |
| 10/28/2001 | CA2307079A1 Inconnu |
| 10/25/2001 | WO2001079114A2 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content |
| 10/25/2001 | WO2001078803A1 Systems, kits, and methods of administering synthetic plasma |
| 10/25/2001 | WO2001078751A1 Antiviral and antibacterial pharmaceutical preparation 'armenicum' and its use for treatment of infectious diseases |
| 10/25/2001 | WO2001078705A2 Compositions containing a naphthalmide and an antiproliferative agent |
| 10/25/2001 | WO2001078701A2 Method and compositions for preventing hormone induced adverse effects |
| 10/25/2001 | WO2001078533A2 Nutritional modules |
| 10/25/2001 | WO2001051064A8 Ph-regulators against oral stereotypies in equines |
| 10/25/2001 | WO2001000245A3 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 10/25/2001 | US20010033861 Liposomes containing an entrapped compound in supersaturated solution |
| 10/25/2001 | US20010033820 Reacting aqueous calcium hydroxide slurry with carbon dioxide |
| 10/25/2001 | CA2405377A1 Nutritional modules |
| 10/25/2001 | CA2404097A1 Method and compositions for preventing hormone induced adverse effects |
| 10/24/2001 | EP1147781A1 Biodegradable implant precursor |
| 10/24/2001 | EP1147214A1 A novel method for designing protein kinase inhibitors |
| 10/24/2001 | EP1146921A1 Cartridge for dialysis containing sodium bicarbonate |
| 10/24/2001 | EP1146874A1 Vitronectin receptor antagonist |
| 10/24/2001 | EP0858341B1 Combination therapy for advanced cancer comprising temozolomide and cisplatin |
| 10/24/2001 | EP0633027B1 Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same |
| 10/24/2001 | EP0547085B1 Basic aluminum and aluminum/zirconium antiperspirants and method of making the same |
| 10/24/2001 | CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 10/24/2001 | CN1318979A Environmentally compatible processes, compositions and materials treated thereby |
| 10/24/2001 | CN1318408A External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation |
| 10/24/2001 | CN1318392A Beriberi treating ointment |
| 10/24/2001 | CN1073443C Medicine for treatment of myopia |
| 10/24/2001 | CN1073435C Infantile cough plaster and its production method |
| 10/24/2001 | CN1073431C Medicine for conditioning intestine and treating diarrhea |
| 10/24/2001 | CN1073425C Clystering liquid for curing lupus colonitis |
| 10/24/2001 | CN1073419C Compound eye drops for preventing and treating eye infection and its preparation |
| 10/23/2001 | US6306838 Targeted vesicular constructs for cyto protection and treatment of h. pylori |
| 10/23/2001 | US6306836 Peritoneal dialysis solutions containing maltodextrins and amino acids |
| 10/23/2001 | US6306384 Skin battery cosmetic composition |
| 10/23/2001 | CA2161009C Analgesic anaesthetic compositions |
| 10/23/2001 | CA2134376C Combinations of polymers for use in physiological tear compositions |
| 10/18/2001 | WO2001076649A1 An injectable bone mineral substitute material |
| 10/18/2001 | WO2001076610A1 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation |
| 10/18/2001 | WO2001076577A2 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity |
| 10/18/2001 | WO2001076567A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 10/18/2001 | WO2001076533A1 Foamable dental fluoride composition |
| 10/18/2001 | US20010031748 Use of metal complexes to treat gastrointestinal infections |
| 10/18/2001 | US20010031744 Using mixture of plant extract and angiogenesis inhibitor |
| 10/18/2001 | US20010031737 Unit dosage forms for the treatment of herpes simplex |
| 10/18/2001 | CA2406484A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 10/18/2001 | CA2405360A1 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity |
| 10/17/2001 | EP1144458A1 Substance for reduction of cholesterol as well as lipids content |
| 10/17/2001 | EP1144311A2 Method for reducing the bromide content in an aqueous bromide-containing solution using hydrogen peroxide |
| 10/17/2001 | EP1144011A2 Prodrug compounds and process for preparation thereof |
| 10/17/2001 | EP1143974A1 Pharmaceutical compositions for alleviating discomfort |
| 10/17/2001 | EP1143955A2 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 10/17/2001 | EP1143914A1 Preparation for dental treatment |
| 10/17/2001 | EP1143913A1 Preparation for dental treatment |
| 10/17/2001 | EP1143799A1 Multi-purpose acid compositions |